Literature DB >> 21586572

Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3.

Christian Ehlting1, Natalia Ronkina, Oliver Böhmer, Ute Albrecht, Konrad A Bode, Karl S Lang, Alexey Kotlyarov, Danuta Radzioch, Matthias Gaestel, Dieter Häussinger, Johannes G Bode.   

Abstract

In LPS-treated macrophages, activation of STAT3 is considered to be crucial for terminating the production of inflammatory cytokines. By analyzing the role of MAPK-activated protein kinase (MK) 2 and MK3 for LPS-induced STAT3 activation in macrophages, the present study provides evidence that MK2 is crucial for STAT3 activation in response to LPS because it prevents MK3 from impeding IFNβ gene expression. Accordingly, LPS-induced IFNβ gene expression is down-regulated in MK2-deficient macrophages and can be reconstituted by additional ablation of the MK3 gene in MK2/3(-/-) macrophages. This is in contrast to LPS-induced IL-10 expression, which essentially requires the presence of MK2. Further analysis of downstream signaling events involved in the transcriptional regulation of IFNβ gene expression suggests that, in the absence of MK2, MK3 impairs interferon regulatory factor 3 protein expression and activation and inhibits nuclear translocation of p65. This inhibition of p65 nuclear translocation coincides with enhanced expression and delayed degradation of IκBβ, whereas expression of IκBα mRNA and protein is impaired in the absence of MK2. The observation that siRNA directed against IκBβ is able to reconstitute IκBα expression in MK2(-/-) macrophages suggests that enhanced expression and delayed degradation of IκBβ and impaired NFκB-dependent IκBα expression are functionally linked. In summary, evidence is provided that MK2 regulates LPS-induced IFNβ expression and downstream STAT3 activation as it restrains MK3 from mediating negative regulatory effects on NFκB- and interferon regulatory factor 3-dependent LPS signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586572      PMCID: PMC3129192          DOI: 10.1074/jbc.M111.235275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

2.  Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.

Authors:  Claudia Niemand; Ariane Nimmesgern; Serge Haan; Patrick Fischer; Fred Schaper; Rolf Rossaint; Peter C Heinrich; Gerhard Müller-Newen
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

3.  IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

Authors:  Ingrid Teige; Alexandra Treschow; Anna Teige; Ragnar Mattsson; Vaidrius Navikas; Tomas Leanderson; Rikard Holmdahl; Shohreh Issazadeh-Navikas
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

4.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

Authors:  Alexander Hoffmann; Andre Levchenko; Martin L Scott; David Baltimore
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

5.  IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.

Authors:  Melanie Scheibel; Bettina Klein; Heidrun Merkle; Manon Schulz; Ralph Fritsch; Florian R Greten; Melek C Arkan; Günter Schneider; Roland M Schmid
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

6.  SOCS3 regulates the plasticity of gp130 signaling.

Authors:  Roland Lang; Anne-Laure Pauleau; Evan Parganas; Yutaka Takahashi; Jörg Mages; James N Ihle; Robert Rutschman; Peter J Murray
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

7.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Authors:  Hideo Yasukawa; Masanobu Ohishi; Hiroyuki Mori; Masaaki Murakami; Takatoshi Chinen; Daisuke Aki; Toshikatsu Hanada; Kiyoshi Takeda; Shizuo Akira; Masahiko Hoshijima; Toshio Hirano; Kenneth R Chien; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

8.  Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock.

Authors:  Shinya Sakaguchi; Hideo Negishi; Masataka Asagiri; Chigusa Nakajima; Tatsuaki Mizutani; Akinori Takaoka; Kenya Honda; Tadatsugu Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  2003-07-11       Impact factor: 3.575

9.  IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

Authors:  Ping Rao; Mathew S Hayden; Meixiao Long; Martin L Scott; A Philip West; Dekai Zhang; Andrea Oeckinghaus; Candace Lynch; Alexander Hoffmann; David Baltimore; Sankar Ghosh
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  31 in total

1.  Characterization of hsp27 kinases activated by elevated aortic pressure in heart.

Authors:  Benoit Boivin; Maya Khairallah; Raymond Cartier; Bruce G Allen
Journal:  Mol Cell Biochem       Date:  2012-08-10       Impact factor: 3.396

2.  Integrative Analysis of MicroRNAs and mRNAs in LPS-Induced Macrophage Inflammation Based on Adipose Tissue Stem Cell Therapy.

Authors:  Xiaozhi Bai; Ting He; Mingchuan Liu; Lincheng Li; Jie Chen; Mengyuan Cao; Yang Liu; Chen Yang; Wenbin Jia; Ke Tao; Juntao Han; Dahai Hu
Journal:  Inflammation       Date:  2020-09-21       Impact factor: 4.092

3.  TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

Authors:  Chaya Levovitz; Dan Chen; Emma Ivansson; Ulf Gyllensten; John P Finnigan; Sara Alshawish; Weijia Zhang; Eric E Schadt; Marshal R Posner; Eric M Genden; Paolo Boffetta; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

4.  Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer.

Authors:  T Melkamu; X Qian; P Upadhyaya; M G O'Sullivan; F Kassie
Journal:  Vet Pathol       Date:  2013-02-04       Impact factor: 2.221

5.  A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling.

Authors:  Peter D Koch; Howard R Miller; Gary Yu; John A Tallarico; Peter K Sorger; Yuan Wang; Yan Feng; Jason R Thomas; Nathan T Ross; Timothy Mitchison
Journal:  ACS Chem Biol       Date:  2018-03-19       Impact factor: 5.100

6.  p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin.

Authors:  Karl Katholnig; Christopher C Kaltenecker; Hiroko Hayakawa; Margit Rosner; Caroline Lassnig; Gerhard J Zlabinger; Matthias Gaestel; Mathias Müller; Markus Hengstschläger; Walter H Hörl; Jin Mo Park; Marcus D Säemann; Thomas Weichhart
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

7.  HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells.

Authors:  Manuela Del Cornò; Gloria Donninelli; Barbara Varano; Letizia Da Sacco; Andrea Masotti; Sandra Gessani
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

8.  Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.

Authors:  Xiaojing Nie; Melinda A Chanley; Ruma Pengal; David B Thomas; Shipra Agrawal; William E Smoyer
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

9.  Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.

Authors:  Lale Ozcan; Canan Kasikara; Arif Yurdagul; George Kuriakose; Brian Hubbard; Michael H Serrano-Wu; Ira Tabas
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

10.  Gentiopicroside (GENT) protects against sepsis induced by lipopolysaccharide (LPS) through the NF-κB signaling pathway.

Authors:  Qiong Wang; Xin Zhou; Long Yang; Maocai Luo; Lei Han; Yao Lu; Qi Shi; Yongjun Wang; Qianqian Liang
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.